Status:
COMPLETED
Vaginal Dinoprostone Administration Prior to Intrauterine Device Insertion
Lead Sponsor:
Cairo University
Conditions:
IUD Insertion Pain
Eligibility:
FEMALE
18-22 years
Phase:
PHASE4
Brief Summary
To investigate whether vaginal dinoprostone administered before the levonorgestrel-releasing intrauterine system(IUs) insertion reduces IUD insertion pain and difficulty in insertion in adolescents an...
Detailed Description
Long-acting reversible contraception methods are highly effective methods for reduction of the unplanned pregnancy rate worldwide. The intrauterine device is a single procedure that provides reliable,...
Eligibility Criteria
Inclusion
- nulliparous adolescent and young women requesting levonorgestrel-releasing intrauterine device
Exclusion
- pregnancy and contraindication or allergy to dinoprostone or contraindication to IUD insertion, chronic pelvic pain,pelvic inflammatory disease,analgesic intake 24 hours prior to IUD insertion.
Key Trial Info
Start Date :
September 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 10 2019
Estimated Enrollment :
130 Patients enrolled
Trial Details
Trial ID
NCT04079140
Start Date
September 15 2019
End Date
December 10 2019
Last Update
July 31 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
faculty of medicine Cairo university
Giza, Egypt, 11231